{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:18:13Z","timestamp":1784269093228,"version":"3.55.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1097\/mcg.0000000000000367","type":"journal-article","created":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T11:38:22Z","timestamp":1434541102000},"page":"647-654","source":"Crossref","is-referenced-by-count":70,"title":["Use of Biologics in Pouchitis"],"prefix":"10.1097","volume":"49","author":[{"given":"Hans H.","family":"Herfarth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie D.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210201","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":". The prevalence and geographic distribution of Crohns disease and ulcerative colitis in the United States.","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R2-6-20210201","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1111\/j.1572-0241.2008.01960.x","article-title":". Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.","volume":"103","author":"Herrinton","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R3-6-20210201","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ibd.20029","article-title":". Update on the incidence and prevalence of Crohns disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.","volume":"13","author":"Loftus","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R4-6-20210201","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/ajg.2009.177","article-title":". The natural history of pediatric ulcerative colitis: a population-based cohort study.","volume":"104","author":"Gower-Rousseau","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R5-6-20210201","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cgh.2008.05.022","article-title":". Natural history of severe ulcerative colitis in a community-based health plan.","volume":"6","author":"Allison","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-6-20210201","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0016-5085(94)90054-X","article-title":". Course of ulcerative colitis: analysis of changes in disease activity over years.","volume":"107","author":"Langholz","year":"1994","journal-title":"Gastroenterology"},{"key":"R7-6-20210201","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/gut.38.2.234","article-title":". Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.","volume":"38","author":"Penna","year":"1996","journal-title":"Gut"},{"key":"R8-6-20210201","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/0016-5085(94)90832-X","article-title":"Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment.","volume":"107","author":"Sandborn","year":"1994","journal-title":"Gastroenterology"},{"key":"R9-6-20210201","first-page":"814","article-title":". Outcome of 200 restorative proctocolectomy operations: the John Radcliffe Hospital experience.","volume":"84","author":"Romanos","year":"1997","journal-title":"Br J Surg"},{"key":"R10-6-20210201","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/00365529309098275","article-title":". Incidence and characteristics of pouchitis in the Kock continent ileostomy and the pelvic pouch.","volume":"28","author":"Svaninger","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"R11-6-20210201","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/bjs.5464","article-title":". Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis.","volume":"94","author":"Hahnloser","year":"2007","journal-title":"Br J Surg"},{"key":"R12-6-20210201","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/DCR.0b013e31819739d6","article-title":". Pouchitis: an evolving clinical enigmaa review.","volume":"52","author":"Coffey","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"R13-6-20210201","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/j.1572-0241.2005.00278.x","article-title":". Clinical approach to diseases of ileal pouch-anal anastomosis.","volume":"100","author":"Shen","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R14-6-20210201","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ajg.2008.127","article-title":". Pathogenesis of and unifying hypothesis for idiopathic pouchitis.","volume":"104","author":"Coffey","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R15-6-20210201","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mcna.2009.08.014","article-title":"Pouchitis and pouch dysfunction.","volume":"94","author":"Wu","year":"2010","journal-title":"Med Clin North Am"},{"key":"R16-6-20210201","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/01.mcg.0000124001.93146.ef","article-title":"The diagnosis and treatment of pouchitis in inflammatory bowel disease.","volume":"38","author":"Cheifetz","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R17-6-20210201","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrgastro.2012.58","article-title":"Acute and chronic pouchitispathogenesis, diagnosis and treatment.","volume":"9","author":"Shen","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R18-6-20210201","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1007\/DCR.0b013e3181a7b77a","article-title":". An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota.","volume":"52","author":"Lim","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"R19-6-20210201","first-page":"858","article-title":"Seksik P, et al..","volume":"14","author":"Sokol","year":"2008","journal-title":"Analysis of bacterial bowel communities of IBD patients: what has it revealed Inflamm Bowel Dis"},{"key":"R20-6-20210201","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cgh.2007.01.001","article-title":". Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation.","volume":"5","author":"Komanduri","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-6-20210201","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s10350-004-6187-z","article-title":". Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis.","volume":"45","author":"Duffy","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"R22-6-20210201","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2036.1999.00553.x","article-title":". Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.","volume":"13","author":"Gionchetti","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R23-6-20210201","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s10350-006-0828-3","article-title":". Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.","volume":"50","author":"Shen","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"R24-6-20210201","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/ibd.20187","article-title":". Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.","volume":"13","author":"Isaacs","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"R25-6-20210201","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/BF02093783","article-title":"Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis.","volume":"39","author":"Madden","year":"1994","journal-title":"Dig Dis Sci"},{"key":"R26-6-20210201","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2036.2002.01203.x","article-title":". Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.","volume":"16","author":"Mimura","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R27-6-20210201","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1521-6918(03)00071-4","article-title":". Probiotics for the treatment of postoperative complications following intestinal surgery.","volume":"17","author":"Gionchetti","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R28-6-20210201","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0016-5085(03)00171-9","article-title":". Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.","volume":"124","author":"Gionchetti","year":"2003","journal-title":"Gastroenterology"},{"key":"R29-6-20210201","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2036.2005.02642.x","article-title":". Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.","volume":"22","author":"Shen","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R30-6-20210201","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s10350-007-9068-4","article-title":". High-dose probiotics for the treatment of active pouchitis.","volume":"50","author":"Gionchetti","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"R31-6-20210201","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":". Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.","volume":"119","author":"Gionchetti","year":"2000","journal-title":"Gastroenterology"},{"key":"R32-6-20210201","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gut.53.1.108","article-title":". Once daily high dose probiotic therapy (VSL3) for maintaining remission in recurrent or refractory pouchitis.","volume":"53","author":"Mimura","year":"2004","journal-title":"Gut"},{"key":"R33-6-20210201","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.2002.01139.x","article-title":". Budesonide enema in pouchitisa double-blind, double-dummy, controlled trial.","volume":"16","author":"Sambuelli","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R34-6-20210201","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1572-0241.2004.30518.x","article-title":". Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis.","volume":"99","author":"Shen","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R35-6-20210201","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198901263200422","article-title":". Topical administration of 5-aminosalicylic acid: a therapeutic proposal for the treatment of pouchitis.","volume":"320","author":"Miglioli","year":"1989","journal-title":"N Engl J Med"},{"key":"R36-6-20210201","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0025-6196(12)62270-8","article-title":"Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study.","volume":"68","author":"Wischmeyer","year":"1993","journal-title":"Mayo Clin Proc"},{"issue":"suppl 1","key":"R37-6-20210201","doi-asserted-by":"crossref","first-page":"A1101","DOI":"10.1016\/S0016-5085(98)84477-6","article-title":"Bismuth subsalicylate tablets for chronic antibiotic-resistant pouchitis.","volume":"114","author":"Tremaine","year":"1998","journal-title":"Gastroenterology"},{"key":"R38-6-20210201","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2036.2009.04163.x","article-title":". Pilot study: the use of sulfasalazine for the treatment of acute pouchitis.","volume":"31","author":"Belluzzi","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R39-6-20210201","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/ajg.2009.138","article-title":". The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis.","volume":"104","author":"Shen","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R40-6-20210201","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/00365520152584815","article-title":". Allopurinol as prophylaxis against pouchitis following ileal pouch-anal anastomosis for ulcerative colitis. A randomized placebo-controlled double-blind study.","volume":"36","author":"Joelsson","year":"2001","journal-title":"Scand J Gastroenterol"},{"key":"R41-6-20210201","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2036.1997.00253.x","article-title":". Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial.","volume":"11","author":"Tremaine","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"R42-6-20210201","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10350-004-6257-2","article-title":". Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis.","volume":"45","author":"Welters","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"R43-6-20210201","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10350-006-0608-0","article-title":". A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis.","volume":"49","author":"Lovegrove","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"R44-6-20210201","first-page":"442","article-title":"Can we immunogenotypically and immunophenotypically profile patients who are at risk for pouchitis Am J Gastroenterol.","volume":"99","author":"Shen","year":"2004","journal-title":""},{"key":"R45-6-20210201","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/gutjnl-2014-307387","article-title":". Gene expression alterations in ulcerative colitis patients after restorative proctocolectomy extend to the small bowel proximal to the pouch.","volume":"64","author":"Yanai","year":"2015","journal-title":"Gut"},{"key":"R46-6-20210201","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/DCR.0b013e3181fc9f04","article-title":". Infliximab andor azathioprine in the treatment of Crohns disease-like complications after IPAA.","volume":"54","author":"Haveran","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"R47-6-20210201","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0b013e318187ed64","article-title":". Long-term outcomes with ileal pouch-anal anastomosis and Crohns disease: pouch retention and implications of delayed diagnosis.","volume":"248","author":"Melton","year":"2008","journal-title":"Ann Surg"},{"key":"R48-6-20210201","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/SLA.0b013e31827d99a2","article-title":". Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients.","volume":"257","author":"Fazio","year":"2013","journal-title":"Ann Surg"},{"key":"R49-6-20210201","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1111\/j.1572-0241.2003.07675.x","article-title":". Management of Crohns disease of the ileoanal pouch with infliximab.","volume":"98","author":"Colombel","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R50-6-20210201","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2036.2008.03656.x","article-title":". Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.","volume":"27","author":"Calabrese","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R51-6-20210201","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2036.2008.03920.x","article-title":". Administration of adalimumab in the treatment of Crohns disease of the ileal pouch.","volume":"29","author":"Shen","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R52-6-20210201","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ibd.21037","article-title":". Efficacy of infliximab in refractory pouchitis and Crohns disease-related complications of the pouch: a Belgian case series.","volume":"16","author":"Ferrante","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R53-6-20210201","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ibd.21821","article-title":". Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study.","volume":"18","author":"Barreiro-de Acosta","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R54-6-20210201","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/ibd.22933","article-title":". Adalimumab therapy in Crohns disease of the ileal pouch.","volume":"18","author":"Li","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"R55-6-20210201","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/gast.1999.0029900429","article-title":". Successful management of Crohns disease of the ileoanal pouch with infliximab.","volume":"117","author":"Ricart","year":"1999","journal-title":"Gastroenterology"},{"key":"R56-6-20210201","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1046\/j.1365-2036.2003.01535.x","article-title":". Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis.","volume":"17","author":"Viscido","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"R57-6-20210201","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00054725-200407000-00013","article-title":"Infliximab therapy in pediatric Crohns pouchitis.","volume":"10","author":"Kooros","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"R58-6-20210201","first-page":"A631","article-title":"Management of pouchitis of the ileoanal pouch with infliximab.","volume":"126","author":"Mohanty","year":"2004","journal-title":"Gastroenterology"},{"key":"R59-6-20210201","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/ibd.20485","article-title":". Successful use of infliximab for treating fistulizing pouchitis with severe extraintestinal manifestation: a case report.","volume":"14","author":"Molnar","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R60-6-20210201","doi-asserted-by":"crossref","first-page":"860394","DOI":"10.1155\/2010\/860394","article-title":"Successful long-term use of infliximab in refractory pouchitis in an adolescent.","volume":"2010","author":"Yeates","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"R61-6-20210201","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s10620-009-0910-5","article-title":". Modulation of Th1Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis.","volume":"55","author":"Akitake","year":"2010","journal-title":"Dig Dis Sci"},{"key":"R62-6-20210201","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/MEG.0b013e3283525a7b","article-title":". Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series.","volume":"24","author":"Barreiro-de Acosta","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R63-6-20210201","first-page":"290","article-title":". One-year infliximab administration for the treatment of chronic refractory pouchitis.","volume":"24","author":"Viazis","year":"2011","journal-title":"Ann Gastroenterol"},{"key":"R64-6-20210201","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.crohns.2013.02.018","article-title":". Long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis.","volume":"7","author":"Viazis","year":"2013","journal-title":"J Crohns Colitis"},{"key":"R65-6-20210201","doi-asserted-by":"crossref","first-page":"S438","DOI":"10.14309\/00000434-201410002-01476","article-title":"A rare case of collagenous pouchitis treated with adalimumab.","volume":"109","author":"Alvarez","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R66-6-20210201","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.2169\/internalmedicine.53.2793","article-title":". One year of infliximab therapy successfully improved a case of refractory pouchitis without the use of antibiotics.","volume":"53","author":"Iizuka","year":"2014","journal-title":"Intern Med"},{"key":"R67-6-20210201","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10350-004-6652-8","article-title":". Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis.","volume":"46","author":"Shen","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"R68-6-20210201","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0025-6196(12)61634-6","article-title":". Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.","volume":"69","author":"Sandborn","year":"1994","journal-title":"Mayo Clin Proc"},{"key":"R69-6-20210201","first-page":"4134","article-title":"Treatment of fistulating pouchitis with tumour necrosis factor-alpha-inhibitor (infliximab).","volume":"170","author":"Semb","year":"2008","journal-title":"Ugeskr Laeger"},{"key":"R70-6-20210201","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00005176-199105000-00005","article-title":". Development and validation of a pediatric Crohns disease activity index.","volume":"12","author":"Hyams","year":"1991","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R71-6-20210201","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/MIB.0000000000000245","article-title":". Benefits and risks of combining anti-tumor necrosis factor with immunomodulator therapy in pediatric inflammatory bowel disease.","volume":"21","author":"Cozijnsen","year":"2015","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0000000000000367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T15:16:01Z","timestamp":1717946161000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201509000-00006"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000000367","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}